IRADIMED CORPORATION (the 'Company” or 'Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and ...
Radimed Corp (IRMD) reports a 17% revenue increase and outlines future growth plans amid challenges in transitioning to new product lines.
For patients with non-large vessel occlusion, acute ischemic stroke and salvageable brain tissue, intravenous tenecteplase ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results